Clorox Company (The) (CLX) Given Average Recommendation of “Hold” by Analysts

Shares of Clorox Company (The) (NYSE:CLX) have been assigned an average rating of “Hold” from the fifteen brokerages that are currently covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $127.39.

Several equities research analysts recently weighed in on CLX shares. Jefferies Group LLC began coverage on Clorox Company (The) in a report on Tuesday, April 18th. They set a “hold” rating and a $138.00 price target for the company. Vetr cut Clorox Company (The) from a “buy” rating to a “hold” rating and set a $139.67 price objective for the company. in a research report on Tuesday, April 18th. Royal Bank Of Canada set a $115.00 price objective on Clorox Company (The) and gave the stock a “hold” rating in a research report on Monday, April 24th. BMO Capital Markets reiterated a “buy” rating and issued a $136.00 price objective on shares of Clorox Company (The) in a research report on Thursday, May 4th. Finally, UBS AG reiterated a “sell” rating and issued a $121.00 price objective (up previously from $117.00) on shares of Clorox Company (The) in a research report on Friday, May 5th.

Clorox Company (CLX) traded up 0.28% during trading on Friday, hitting $134.31. 526,295 shares of the stock traded hands. Clorox Company has a 12 month low of $111.24 and a 12 month high of $141.76. The firm’s 50-day moving average is $133.58 and its 200-day moving average is $133.56. The stock has a market cap of $17.34 billion, a P/E ratio of 25.18 and a beta of 0.40.

Clorox Company (The) (NYSE:CLX) last issued its quarterly earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.49 by $0.04. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The firm had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.65 billion. During the same period last year, the company earned $1.30 earnings per share. The company’s revenue for the quarter was up 2.9% on a year-over-year basis. On average, analysts forecast that Clorox Company will post $5.67 EPS for the current year.

TRADEMARK VIOLATION WARNING: This piece was originally posted by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this piece on another domain, it was stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece can be accessed at https://stocknewstimes.com/2017/08/12/clorox-company-the-clx-given-average-recommendation-of-hold-by-analysts.html.

Several hedge funds and other institutional investors have recently made changes to their positions in CLX. Jacobi Capital Management LLC boosted its position in shares of Clorox Company (The) by 0.3% in the first quarter. Jacobi Capital Management LLC now owns 1,282 shares of the company’s stock worth $172,000 after buying an additional 4 shares in the last quarter. Bridgeworth LLC boosted its position in shares of Clorox Company (The) by 0.3% in the first quarter. Bridgeworth LLC now owns 1,869 shares of the company’s stock worth $252,000 after buying an additional 5 shares in the last quarter. Valley National Advisers Inc. boosted its position in shares of Clorox Company (The) by 0.6% in the first quarter. Valley National Advisers Inc. now owns 860 shares of the company’s stock worth $116,000 after buying an additional 5 shares in the last quarter. Blue Chip Partners Inc. boosted its position in shares of Clorox Company (The) by 0.7% in the first quarter. Blue Chip Partners Inc. now owns 906 shares of the company’s stock worth $122,000 after buying an additional 6 shares in the last quarter. Finally, Bernzott Capital Advisors boosted its position in shares of Clorox Company (The) by 0.4% in the second quarter. Bernzott Capital Advisors now owns 1,607 shares of the company’s stock worth $214,000 after buying an additional 7 shares in the last quarter. Institutional investors and hedge funds own 70.29% of the company’s stock.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Analyst Recommendations for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply